Health Catalyst, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $246.76M
  • PE -4
  • Debt $623.57M
  • Cash $249.65M
  • EV $620.68M
  • FCF $12.94M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$69.50M
EBIT-$68.53M
ROE-19%
ROA-8%
FCF$12.94M
Equity$365.21M
Growth Stability1
PE-3.55
PB0.68
P/FCF19.06
P/S0.8
Price/Cash1.01
Debt/Equity1.71
Debt/FCF48.18
Net Margins-23%
Gross Margins46%
Op. Margins-22%
Sales Growth YoY6%
Sales Growth QoQ4%
Sales CAGR19%
Equity CAGR11%
Earnings Growth YoY-32%
Earnings Growth QoQ40%
Sales CAGR 5Y14%
Equity CAGR 5Y8%
Earnings CAGR 3Y6%
Sales CAGR 3Y6%
Equity CAGR 3Y-11%
Market Cap$246.76M
Revenue$306.58M
Assets$858.93M
Total Debt$623.57M
Cash$249.65M
Shares Outstanding60.18M
EV620.68M
Moat Score4%
Safety Score68%
Working Capital139.8M
Current Ratio1.43
Gross Profit$140.78M
Shares Growth 3y5%
Equity Growth QoQ3%
Equity Growth YoY-0%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

SEC Filings

Direct access to Health Catalyst, Inc. (HCAT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Health Catalyst, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Health Catalyst, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Health Catalyst, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Health Catalyst, Inc..

= $129M
012345678910TV
fcf$13M$13M$13M$13M$13M$13M$13M$13M$13M$13M$13M$129M
DCF$12M$11M$9.7M$8.8M$8M$7.3M$6.6M$6M$5.5M$5M$50M
Value$129M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins-80%-101%-155%-61%-63%-50%-40%-23%-23%
ROA---18%-17%-17%-19%-15%-8%-8%
ROE---120%-42%-29%-32%-32%-19%-19%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF---1.39-4.98-5.39-6.05-6.748.1848.18
Debt over Equity--0.050.240.610.350.530.631.711.71
Growth Stability--------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-54%38%22%28%14%7%4%14%
Earnings YoY growth-94%111%-52%33%-10%-14%-41%-
Equity YoY growth-44%-154%38%89%-19%-14%-0%8%
FCF YoY growth-8%-19%-2%-1%12%-8%-138%-